Comparative Effectiveness of Duloxetine and Pelvic Floor Exercises for Stress Urinary Incontinence in Postmenopausal Women: A Quasi-Experimental Study in a Secondary Care Setting, Islamabad
Exercises for Stress Urinary Incontinence
DOI:
https://doi.org/10.54393/pjhs.v6i5.3020Keywords:
Stress Urinary Incontinence, Postmenopausal Women, Duloxetine, Pelvic Floor ExercisesAbstract
Stress urinary incontinence has great impact on female daily activities, emotional well-being, and overall quality of life; hence the need of most effective treatment is mandatory. Objective: To evaluate the effectiveness of Duloxetine and Pelvic Floor Muscle Training (PFMT) in the management of Stress Urinary Incontinence (SUI) in postmenopausal women. This study also aims to estimate symptom reduction, adherence rates, quality of life, and associated factors. Methods: Sample consist of 100 participants who were randomly assigned to two groups: Duloxetine (n=50) and PFMT (n=50). Reduction in weekly incontinence episodes over the period of 12 weeks was considered as the primary outcome. Improvement in quality of life, adherence rates, strengthening pelvic floor muscle and reduction in adverse effects was considered as the secondary outcome. Results: A considerable reduction in the weekly incontinence episodes was seen in both groups and no statistically significant difference (p = 0.08) was found among two groups. Similarly, quality of life scores was also improved significantly (p < 0.001), post intervention with PFMT group exhibiting a marginal advantage. Only the PFMT group exhibited significant pelvic floor muscle strengthening (p < 0.001). Mild adverse effects, including nausea and fatigue, were reported in 12% of participants in the Duloxetine group, while PFMT had no reported side effects. Conclusions: Both Duloxetine and PFMT effectively reduced SUI symptoms and improved quality of life. However, PFMT had advantages in adherence, safety, and pelvic floor muscle strengthening, making it the preferred first-line treatment.
References
Hammad FT. Prevalence, social impact and help-seeking behaviour among women with urinary incontinence in the Gulf countries: a systematic review. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2021 Nov; 266: 150-6. doi: 10.1016/j.ejogrb.2021.10.005.
Huang H, Ding G, Li M, Deng Y, Cheng Y, Jin H. Menopause and stress urinary incontinence: the risk factors of stress urinary incontinence in perimenopausal and postmenopausal women. Journal of Obstetrics and Gynaecology Research. 2023 Oct; 49(10): 2509-18. doi: 10.1111/jog.15742.
Kołodyńska G, Zalewski M, Rożek-Piechura K. Urinary incontinence in postmenopausal women-causes, symptoms, treatment. Menopause Review/Przegląd Menopauzalny. 2019 Apr; 18(1): 46-50. doi: 10.5114/pm.2019.84157.
Clark AL. Overactive bladder, stress urinary incontinence, and menopause-what are the associations?. Menopause. 2022 Feb; 29(2): 125-6. doi: 10.1097/GME.0000000000001929.
Soares TG, Barbosa JM, Sampaio NR, Corrêa UC, da Silva SL, de Oliveira Sunemi MM et al. Prevalence and factors associated with urinary incontinence in community-dwelling older adults. 2024 Jan. doi: 10.21203/rs.3.rs-3895604/v1.
Gümüşsoy S, Öztürk R, Kavlak O, Hortu İ, Yeniel AÖ. Investigating pelvic floor muscle strength in women of reproductive age and factors affecting it. Clinical Nursing Research. 2021 Sep; 30(7): 1047-58. doi: 10.1177/10547738211000350.
Jha S, Jeppson PC, Dokmeci F, Marquini GV, Sartori MG, Moalli P et al. Management of mixed urinary incontinence: IUGA committee opinion. International Urogynecology Journal. 2024 Feb; 35(2): 291-301. doi: 10.1007/s00192-023-05694-z.
Biyikoglu M, Kettas E, Sesli M, Senel S, Cayan S, Akbay E. The effect of duloxetine on female sexual functions in the treatment of stress incontinence. Archives of Gynecology and Obstetrics. 2023 Sep; 308(3): 1037-42. doi: 10.1007/s00404-023-07123-4.
Hagovska M, Svihra J, Breza J, Dubravicky J, Vargovcak M. A randomized, intervention parallel multicentre study to evaluate duloxetine and innovative pelvic floor muscle training in women with uncomplicated stress urinary incontinence-the DULOXING study. International Urogynecology Journal. 2021 Jan; 32: 193-201. doi: 10.1007/s00192-020-04516-w.
Lorzadeh N and Jahanshahi M. The effect of duloxetine on stress urinary incontinence. Health Science Reports. 2024 May; 7(5): e2091. doi: 10.1002/hsr2.2091.
Baldaçara L. Duloxetine: an update. Research, Society and Development. 2024 Mar; 13(3): e7313345331-. doi: 10.33448/rsd-v13i3.45331.
Mangir N, Uçar M, Gülpinar Ö, Özkürkçügil C, Tarcan T. Duloxetine in the treatment of women with urinary incontinence: a systematic review and Meta-analysis of Efficacy Data from Randomized Controlled clinical trials. Journal of Urological Surgery. 2023; 10(1). doi: 10.4274/jus.galenos.2022.2022.0027.
Todhunter-Brown A, Hazelton C, Campbell P, Elders A, Hagen S, McClurg D. Conservative interventions for treating urinary incontinence in women: an overview of Cochrane systematic reviews. Cochrane Database of Systematic Reviews. 2022; (9). doi: 10.1002/14651858.CD012337.pub2.
Lakens D. Sample size justification. Collabra: psychology. 2022 Mar; 8(1): 33267. doi: 10.1525/collabra.33267.
Prasad JB, Tyagi NK, Verma P. Age at menopause in India: A systematic review. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2021 Jan; 15(1): 373-7. doi: 10.1016/j.dsx.2021.01.013.
Ghroubi S, El Fani N, Elarem S, Alila S, Ben Ayed H, Borgi O et al. Arabic (Tunisian) translation and validation of the urogenital distress inventory short form (UDI-6) and incontinence impact questionnaire short form (IIQ-7). Arab Journal of Urology. 2020 Jan; 18(1): 27-33. doi: 10.1080/2090598X.2019.1678000.
Seyan ZJ, Papp SB, Christie AL, Zimmern PE. Systematic Review of the Global Use of Validated Questionnaires in the Management of Stress Urinary Incontinence in Women. Urology Practice. 2024 Sep; 11(5): 834-9. doi: 10.1097/UPJ.0000000000000617.
Mikuš M, Ćorić M, Matak L, Škegro B, Vujić G, Banović V. Validation of the UDI-6 and the ICIQ-UI SF-Croatian version. International Urogynecology Journal. 2020 Dec; 31: 2625-30. doi: 10.1007/s00192-020-04500-4.
Patrick DL, Khalaf KM, Dmochowski R, Kowalski JW, Globe DR. Psychometric performance of the incontinence quality-of-life questionnaire among patients with overactive bladder and urinary incontinence. Clinical Therapeutics. 2013 Jun; 35(6): 836-45. doi: 10.1016/j.clinthera.2013.04.013.
Park JJ, Kwon A, Noh TI, Gwon YN, Shim SR, Kim JH. Efficacy of pelvic floor muscle exercise or therapy with or without duloxetine: a systematic review and network meta-analysis. The Aging Male. 2022 Dec; 25(1): 145-55. doi: 10.1080/13685538.2022.2069238.
Nightingale G. Management of urinary incontinence. Post Reproductive Health. 2020 Jun; 26(2): 63-70. doi: 10.1177/2053369120927112.
Chapple LA, Fetterplace K, Asrani V, Burrell A, Cheng AC, Collins P et al. Nutrition management for critically and acutely unwell hospitalised patients with coronavirus disease 2019 (COVID‐19) in Australia and New Zealand. Nutrition & Dietetics. 2020 Sep; 77(4): 426-36. doi: 10.1111/1747-0080.12636.
Niarchou E, Roberts LH, Naughton BD. What is the impact of antidepressant side effects on medication adherence among adult patients diagnosed with depressive disorder: A systematic review. Journal of Psychopharmacology. 2024 Feb; 38(2): 127-36. doi: 10.1177/02698811231224171.
Fang J, Ye J, Huang Q, Lin Y, Weng Y, Wang M et al. Risk factors of pelvic floor muscle strength in south Chinese women: a retrospective study. BioMed Central Pregnancy and Childbirth. 2022 Aug; 22(1): 624. doi: 10.1186/s12884-022-04952-0.
Al-Dossari R, Kalra M, Adkison J, Nguyen BM. Non-surgical management of urinary incontinence. The Journal of the American Board of Family Medicine. 2024 Sep; 37(5): 909-18. doi: 10.3122/jabfm.2023.230471R1.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Pakistan Journal of Health Sciences

This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments